Fmr LLC boosted its holdings in The Joint Corp. (NASDAQ:JYNT – Free Report) by 38.0% during the third quarter, Holdings Channel.com reports. The fund owned 10,787 shares of the company’s stock after acquiring an additional 2,971 shares during the period. Fmr LLC’s holdings in Joint were worth $123,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the business. Renaissance Technologies LLC lifted its holdings in shares of Joint by 5.5% in the second quarter. Renaissance Technologies LLC now owns 394,478 shares of the company’s stock valued at $5,546,000 after purchasing an additional 20,400 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Joint by 9.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 194,139 shares of the company’s stock worth $2,730,000 after purchasing an additional 17,268 shares during the last quarter. Clayton Partners LLC lifted its stake in Joint by 38.1% in the 2nd quarter. Clayton Partners LLC now owns 186,500 shares of the company’s stock valued at $2,622,000 after buying an additional 51,500 shares in the last quarter. Douglass Winthrop Advisors LLC grew its holdings in Joint by 4.1% during the 3rd quarter. Douglass Winthrop Advisors LLC now owns 146,400 shares of the company’s stock valued at $1,675,000 after buying an additional 5,800 shares during the last quarter. Finally, Verus Capital Partners LLC grew its holdings in Joint by 5.9% during the 3rd quarter. Verus Capital Partners LLC now owns 132,955 shares of the company’s stock valued at $1,521,000 after buying an additional 7,440 shares during the last quarter. 76.88% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages have recently issued reports on JYNT. StockNews.com upgraded Joint from a “hold” rating to a “buy” rating in a research report on Friday, November 15th. Roth Mkm reduced their target price on shares of Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, November 8th.
Joint Stock Performance
JYNT stock opened at $10.27 on Monday. The company has a 50 day moving average price of $11.35 and a two-hundred day moving average price of $12.11. The stock has a market capitalization of $153.89 million, a P/E ratio of -9.01 and a beta of 1.57. The Joint Corp. has a one year low of $8.88 and a one year high of $17.82.
Joint Company Profile
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Articles
- Five stocks we like better than Joint
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What Are Earnings Reports?
- CarMax Gets in Gear: Is Now the Time to Buy?
- Using the MarketBeat Dividend Yield Calculator
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Want to see what other hedge funds are holding JYNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Joint Corp. (NASDAQ:JYNT – Free Report).
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.